Elucidata Launches AI Labs to Solve Biomedical AGI
Elucidata today announced the launch of the AI Lab, an initiative focused on advancing Artificial General Intelligence (AGI) across multiple research areas in Biomedical R&D, starting with one of the hardest blockers to reliable, real world AI: out-of-distribution (OOD) problems.
Elucidata and Sapien Biosciences Announce Strategic Partnership to Transform Biobank Assets into high quality AI Products
Elucidata, a leader in data-centric AI for drug discovery and translational research, and Sapien Biosciences, India's first and largest commercial biobank with 300,000+ patient samples founded in partnership with Apollo Hospitals, today announced a strategic partnership to convert Sapien’s extensive biobank assets into AI-ready, multimodal data products for use in drug and diagnostic development.
Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner
Elucidata, the leading data-centric AI solutions and technology company, is proud to welcome Dr. Werner Lanthaler and Dr. Navjot Singh to its leadership team as Independent Board Member and Advisor, respectively. Recognized as the Most Innovative Biotech Company by Fast Company and the winner of the National Cancer Institute's AI-Readiness Challenge, Elucidata is poised to further accelerate the application of AI across healthcare, life-sciences and diagnostics.
